On Monday, in the course of current trade, Shares of Albemarle Corporation (NYSE:ALB), dropped -0.55%, and is now trading at $45.05.
Albemarle Corporation was presented with the prestigious 2015 National Mining Society award for its valuable contributions to the advancement of the lithium industry in Chile. Albemarle, with operations in La Negra, Chile and Salar de Atacama, Chile, has made significant investments in R&D and production capacity in the region.
“Over the past three decades, we’ve been focused on developing innovative products and processes to not only satisfy international lithium demand, but to elevate Chile as a world leader in lithium production,” stated Stephen Elgueta, General Manager for Albemarle’s Chilean operations. “We are thrilled to be recognized by the National Mining Society for our efforts and look forward to continuing the advancement of lithium extraction and processing technology while sustaining the cultural and natural significance of the region.”
The award was presented to Rockwood Lithium on August 28 at an annual banquet in Santiago, Chile. The event was hosted by the National Mining Society and attended by various industry and government representatives, including Chilean President, Michelle Bachelet. During the banquet, the company was also among the finalists for the coveted John T. Ryan award due to its exemplary safety record in 2014.
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. The company’s Performance Chemicals segment offers brominated flame retardants under the Saytex brand; mineral-based flame retardants under the Martinal and Magnifin brands; and elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and bromine fine chemicals that are used in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, paper manufacturing, water purification, beef and poultry processing, and various other industrial applications.
During an Afternoon trade, Shares of Scripps Networks Interactive, Inc. (NYSE:SNI), climbed 0.24%, and is now trading at $53.28.
Scripps Networks Interactive has promoted two of its senior management team into key roles designed to enhance the company’s ability to produce, market and monetize lifestyle video content.
Burton Jablin, currently President of Scripps Networks, has been appointed Chief Operating Officer of Scripps Networks Interactive. In his new role, Jablin will oversee sales, distribution, programming, digital and strategic planning for the company. He will also be tasked with ensuring greater coordination and cooperation between Scripps Networks’ domestic and international programming, as the business continues to expand globally. He will continue to report to Scripps Networks Interactive Chairman, President, and Chief Executive Officer Kenneth W. Lowe.
Kathleen Finch, currently President of HGTV, DIY Network and Great American Country, has been appointed Chief Programming, Content & Brand Officer, and will take overall responsibility for content across all six of Scripps’ domestic networks including Food Network, Cooking Channel and Travel Channel. She will work out of Scripps Networks’ offices in Knoxville and New York City, and will report to Jablin.
Scripps Networks Interactive, Inc. develops lifestyle-oriented content for linear and interactive video platforms in the United States, the United Kingdom and other European markets, the Middle East and Africa, the Asia-Pacific, and Latin America.
Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO), during its Monday’s current trading session fell -1.74%, and is now trading at $18.09.
Halozyme Therapeutics named Michael J. LaBarre, Ph.D. as chief scientific officer, succeeding Dr. Michael Shepard, who was appointed a Research Fellow for the company.
The move broadens Dr. LaBarre’s responsibilities to include research and development of early pipeline assets, in addition to his role managing product development and ENHANZE™ platform partnerships.
“Mike has deep experience characterizing early stage assets, making him an ideal leader for our research organization as we invest further in our promising pipeline,” said Dr. Helen Torley, president and chief executive officer. “We have a full agenda for the second half of 2015 as we broaden the study of our investigational new drug PEGPH20 in multiple tumor types and prepare for our pivotal phase 3 studies in pancreatic cancer patients. I am pleased to have a proven leader of Mike’s caliber to guide our research efforts as we invest for future growth.”
Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other drugs or can be used to alter abnormal tissue structures for clinical benefit.
Finally, CME Group Inc (NASDAQ:CME), gained 0.08% Friday.
Canadian Metals Inc., has retained Celtis Capital Inc. for coordinating the preliminary economic assessment (PEA) of implementing a ferrosilicon plant with a planned capacity of 50,000 metric tonnes per annum at a site to be determined in the Province of Quebec. The contemplated ferrosilicon project aims at the partial downstream integration of the Langis silica deposit located in Quebec’s Matapedia region for supplying world markets. Ferrosilicon is essentially used as a source of silicon to reduce metals from their oxides and to deoxidize steel and other ferrous alloys. All aspects of the contemplated project will be integrated into the PEA as developed by various qualified professionals retained and to be retained by CME, including geological studies, process engineering, site selection, engineering of plant facilities, capital and operating cost estimates, market studies, environmental studies, and economic analysis.
Mr. Guy Ouimet, Eng., MBA, ICD.D is the managing partner of Celtis Capital Inc. and will coordinate the PEA on behalf of CME. Mr. Ouimet is a seasoned professional specialized in industrial project development and financing. Over more than thirty years he has conducted many similar assignments for institutional and strategic investors including Societe Generale de Financement du Quebec and The Rima Group, namely in the areas of ferroalloys, silicon metal and light metals.
CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products for trading and/or clearing across various asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
